NIH awards Lentigen a SBIR grant for program to generate Hepatitis C Virus-Like Particles
Links shared publicly online about this topic.
- 1,543total visits
NIH awards Lentigen a SBIR grant for program to generate Hepatitis C Virus-Like Particles
Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today that it has received a National Institutes of Health (NIH) small business innovation research (SBIR) grant for a program on "A Novel Method of Generating Hepatitis C Virus-Like Particles using Lentivirus". In this program, Lentigen will collaborate with Epixis SA (Paris, France).
View full resource at news-medical.net
Tags: Liver Condition, Hepatitis, Hepatitis C, Genes, National Institutes of Health
Most Recently Shared on December 9, 2009 at 5:42 pm By:
NIH awards Lentigen a SBIR grant for program to generate Hepatitis C Virus-Like Particles: Lentigen Corporation, a ... http://bit.ly/7wv1G6
Advertisement
